Print this documentEmail this document
Conquering disease through knowledge

Current Studies

The Physicians at Genova Clinical Research have participated in and may have current research studies involving:

Insomnia

Genova Clinical Research, Inc. is looking for participants to enroll in a clinical research study that is evaluating the safety and efficacy of an investigational medication vs. placebo (an inactive substance) for the treatment of insomnia. This study lasts approximately 12 months and includes 12 study office visits. Study related lab work; physical exams lab work and study medications are included at no charge. Qualified participants may receive compensation of $40.00 for each completed visit.

Interested participants must:

If you are interested in finding out more about this study please call us at 520-219-6394. One of our staff will give you further information regarding this study and will schedule you an appointment so you may review the study in more detail with one of our study physicians. Volunteer participation in research is one way that investigational medications can be approved for the future. We appreciate your interest in this study and look forward to hearing from you.

GERD

Genova Clinical Research is currently conducting a clinical research study of an investigational medication versus placebo (an inactive substance) for the treatment of sleep disturbances caused by acid reflux also known as GERD or heartburn. This study lasts approximately 7 weeks and includes 3 office visits. Qualified participants will receive study related medications, physical examinations, and lab work at no charge. Compensation may be available for time and travel to qualified participants.

Subjects interested in this study should:

If you are interested in finding out more about this study please call us at 520-219-6394. One of our staff will be happy to give you further information regarding this study and will schedule you an appointment so you can review the study in more detail with one of our physicians.